Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 11, 2017
Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge ModelGail Torkildsen, Mark B Abelson, Paul J Gomes, et al.
Ophthalmology|October 1, 1984
Vernal conjunctivitis in the hyperimmunoglobulinemia E syndromeS I Butrus, D Y Leung, S Gellis, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 17, 2014
Blink patterns and lid-contact times in dry-eye and normal subjectsGeorge W Ousler, Mark B Abelson, Patrick R Johnston, et al.
Investigative Ophthalmology & Visual Science|June 13, 2015
Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry EyeJohn D Rodriguez, Keith J Lane, George W Ousler, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2024
Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical TrialsJohn D Rodriguez, Samantha Kerti, Adam Hamm, et al.
American Journal of Ophthalmology|April 15, 1994
Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitisC I Santos, A J Huang, M B Abelson, et al.
Current Eye Research|October 19, 2017
Blink: Characteristics, Controls, and Relation to Dry EyesJohn D Rodriguez, Keith J Lane, George W Ousler, et al.
Investigative Ophthalmology & Visual Science|August 1, 1989
Dynamics of corneal epithelial healing after an alkali burn. A statistical analysisL D Ormerod, A Garsd, C V Reddy, et al.
Allergy and Asthma Proceedings|September 22, 2007
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitisMark B Abelson, Paul J Gomes, Terri Pasquine, et al.
Pageof 13